In the present study, we demonstrated that THSWD attenuated mitochondrial DNA and nuclear DNA damage during stroke; reduced AIM2, NLRC4, and Caspase-1 inflammasomes; and inhibited IL-1β and IL-18 inflammatory factor release after IS. This evidence concerns the gene IL1B and stroke disorder.